ArticleClinical pharmacology in drug development2026
The Pathway to Proof-of-Concept for BNC210, a Negative Allosteric Modulator of the Alpha-7 Nicotinic Acetylcholine Receptor (nAChR), for Treatment of Psychiatric Disease.
Paul Rolan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.